3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Glioma
3
Wilms Tumor
2
Sarcoma
2
Rhabdomyosarcoma
2
Rhabdoid Tumor
2
Osteosarcoma
2
Neuroectodermal Tumors, Primitive, Peripheral
2
Neuroblastoma
2
Multiple Myeloma
2
Medulloblastoma
2
Lymphoma, Non-Hodgkin
2
Lymphoma
2
Histiocytosis, Langerhans-Cell
2
Hepatoblastoma
2
Ependymoma
2
Central Nervous System Neoplasms
2
Xanthogranuloma, Juvenile
1
Uterine Neoplasms
1
Uterine Cervical Neoplasms
1
Urinary Bladder Neoplasms
1
Thyroid Neoplasms
1
Stomach Neoplasms
1
Sarcoma, Ewing
1
Rectal Neoplasms
1
Prostatic Neoplasms
1
Pancreatic Neoplasms
1
Ovarian Neoplasms
1
Melanoma
1
Lung Neoplasms
1
Histiocytic Sarcoma
1
Interventions
pembrolizumab
19
Bevacizumab
14
Carboplatin
11
Standard of Care
10
Cyclophosphamide
9
Nivolumab
8
Cetuximab
8
Exercise
7
Doxorubicin
7
atezolizumab
6
Temozolomide
6
Radiotherapy
6
Pemetrexed
6
Paclitaxel
6
Blood Specimen Collection
6
durvalumab
5
Rituximab
5
Prednisone
5
Fluorouracil
5
Cisplatin
5
olaparib
4
dostarlimab
4
abemaciclib
4
Leucovorin
4
Gemcitabine
4
130-nm albumin-bound paclitaxel
4
venetoclax
3
temsirolimus
3
talazoparib
3
pertuzumab
3
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Neoplasms
×
larotrectinib
×
30 days
×
Clear all
No trials found.